CMN-005 is under clinical development by Benecyte and currently in Phase II for Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma). According to GlobalData, ...

ET-901 is under clinical development by EdiGene and currently in Phase II for Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma). According to GlobalData, ...

Center for Cell Structure and Function, Shandong Provincial Key Laboratory of Animal Resistance Biology, College of Life Sciences, Shandong Normal University, Jinan, Shandong 250014, China ...

The mucosal surfaces are lined by epithelial cells, establishing a barrier between the external environment and internal milieu. There are many strategies to follow in order to cross the mucus ...

Shape changes of epithelia during animal development, such as convergent extension, are achieved through concerted mechanical activity of individual cells. While much is known about the corresponding ...

Shape changes of epithelia during animal development, such as convergent extension, are achieved through the concerted mechanical activity of individual cells. While much is known about the ...

Various enterotoxins interact with cells of the digestive mucosa by using a primarily membrane ... physiological modulator of the intestinal epithelial barrier. Using immunopurification based ...

1 Department of Anatomy and Developmental Biology, Monash University, Clayton, VIC, Australia 2 Development and Stem Cells Program, Monash Biomedicine Discovery Institute, Clayton, VIC, Australia ...

Furthermore, mucosal biopsies and resection specimen of healthy individuals and IBD patients before the start of anti-tumor necrosis factor (anti-TNF) therapy were obtained for immunohistochemistry ...